Sociedad Americana de Hirudoterapia

Microvascular ear replantation: a multicenter study of 22 patients with complete ear amputation

Multicenter study published in Facial Plast Surg Aesthet Med (2021)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studyEnsayos clínicosJiang Y et al. · Facial plastic surgery & aesthetic medicine, 2021

Abstract

Background: We aimed to report our experience in treating ear amputations with microvascular replantation, with the largest sample to date. Methods: Twenty-two patients with complete ear amputation underwent microvascular ear replantation at three medical centers between May 2003 and May 2020. Arterial anastomoses, venous anastomoses, or vein graft were performed depending on different situations. Re-exploration was performed in four patients due to venous congestion (n = 3) or arterial compromise (n = 1). Results: Eleven patients had vascular complications (venous congestion: 10, arterial compromise: 1) and four of them required re-exploration. Three ears were completely salvaged (75%) and one case failed. Eighteen (81.8%) replanted ears survived completely, with 15 repaired ears demonstrating a good contour and 3 ears showing atrophy. Three replanted ears sustained partial loss, and one sustained total loss. Three extraordinary cases with the longest ischemic time, smallest tissue size, and youngest age reported thus far all survived and had cosmetically satisfactory appearances. Statistical analysis indicated no significant correlation between replanted ear survival and potentially influential factors, including ischemic time, number of arterial and venous anastomoses, presence of vein graft, and re-exploration. Conclusions: Microvascular replantation for ear amputations achieved excellent results. It may be considered the primary choice for surgeons with microsurgical skill.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov't
Indexed MeSH termsHumansReplantationMaleFemaleAdultAmputation, TraumaticMiddle AgedAdolescentMicrosurgeryEar, ExternalYoung AdultChild

Resumen

Largest-to-date series of 22 microvascular ear replantations across 3 centers. 81.8% complete survival; 11/22 had vascular complications including 10 venous congestion cases.

Por qué esto importa para la hirudoterapia

This multicenter study reports outcomes of microvascular ear replantation in 22 patients with complete ear amputation, achieving an 81.8% complete survival rate. Venous congestion was the most common vascular complication (10 of 22 patients). The study makes no mention of leech therapy or hirudotherapy. While ear replantation complicated by venous congestion is a clinical scenario where medicinal leeches are sometimes employed adjunctively, this study does not describe any leech-related intervention. Relevance to ASH's domain is indirect, limited to the surgical context where venous congestion management challenges arise. The focus is on surgical technique and outcomes rather than adjunctive congestion therapies.

Citación

Microvascular ear replantation: a multicenter study of 22 patients with complete ear amputation.

Jiang Y et al. · Facial plastic surgery & aesthetic medicine, 2021

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.